UROTENSIN II MEDIATES ERK1/2 PHOSPHORYLATION AND PROLIFERATION IN GPR14-TRANSFECTED CELL LINES

REFERENCES

• Pearson D., Shively J. E., Clark B. R., Geschwind II, Barkley M., Nishioka R. S., Bern H. A. Urotensin II: A Somatostatin-Like Peptide in the Caudal Neurosecretory System of Fishes. Proc. Natl. Acad. Sci. USA 1980; 77: 5021–5024
   PubMed Web of Science ®Google Scholar
• Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J. C., Conlon J. M., Bern H. A., Vaudry H. Cloning of the cDNA Encoding the Urotensin II Precursor in Frog and Human Reveals Intense Expression of the Urotensin II Gene in Motoneurons of the Spinal Cord. Proc. Natl. Acad. Sci. USA 1998; 95: 15803–1508
   PubMed Web of Science ®Google Scholar
• Medakovic M., Chan D. K., Lederis K. Pharmacological Effects of Urotensins. I. Regional Vascular Effects of Urotensins I and II in the Rat. Pharmacology 1975; 13: 409–418
   PubMedGoogle Scholar
• Itoh H., Itoh Y., Rivier J., Lederis K. Contraction of Major Artery Segments of Rat by Fish Neuropeptide Urotensin II. Am. J. Physiol. 1987; 252: R361–R366
   Google Scholar
• Douglas S. A., Ashton D. J., Sauermelch C. F., Coatney R. W., Ohlstein D. H., Ruffolo M. R., Ohlstein E. H., Aiyar N. V., Willette R. N. Human Urotensin-II is a Potent Vasoactive Peptide: Pharmacological Characterization in the Rat, Mouse, Dog and Primate. J. Cardiovasc. Pharmacol. 2000; 36: S163–S166
   Web of Science ®Google Scholar
• Douglas S. A., Sulpizio A. C., Piercy V., Sarau H. M., Ames R. S., Aiyar N. V., Ohlstein E. H., Willette R. N. Differential Vasoconstrictor Activity of Human Urotensin-II in Vascular Tissue Isolated from the Rat, Mouse, Dog, Pig, Marmoset and Cynomolgus Monkey. Br. J. Pharmacol. 2000; 131: 1262–1274
   PubMed Web of Science ®Google Scholar
• Gibson A. Complex Effects of Gillichthys Urotensin II on Rat Aortic Strips. Br. J. Pharmacol. 1987; 91: 205–212
   PubMed Web of Science ®Google Scholar
• Gibson A., Wallace P., Bern H. A. Cardiovascular Effects of Urotensin II in Anesthetized and Pithed Rats. Gen. Comp. Endocrinol. 1986; 64: 435–439
   PubMed Web of Science ®Google Scholar
• Hillier C., Berry C., Petrie M. C., O'Dwyer P. J., Hamilton C., Brown A., McMurray J. Effects of Urotensin II in Human Arteries and Veins of Varying Caliber. Circulation 2001; 103: 1378–1381
   PubMed Web of Science ®Google Scholar
• MacLean M. R., Alexander D., Stirrat A., Gallagher M., Douglas S. A., Ohlstein E. H., Morecroft I., Polland K. Contractile Responses to Human Urotensin-II in Rat and Human Pulmonary Arteries: Effect of Endothelial Factors and Chronic Hypoxia in the Rat. Br. J. Pharmacol. 2000; 130: 201–204
   PubMed Web of Science ®Google Scholar
• Tal M., Ammar D. A., Karpuj M., Krizhanovsky V., Naim M., Thompson D. A. A Novel Putative Neuropeptide Receptor Expressed in Neural Tissue, Including Sensory Epithelia. Biochem. Biophys. Res. Commun. 1995; 209: 752–759
   PubMed Web of Science ®Google Scholar
• Ames R. S., Sarau H. M., Chambers J. K., Willette R. N., Aiyar N. V., Romanic A. M., Louden C. S., Foley J. J., Sauermelch C. F., Coatney R. W., Ao Z., Disa J., Holmes S. D., Stadel J. M., Martin J. D., Liu W-S., Glover G. I., Wilson S., McNulty D. E., Ellis C. E., Elshourbagy N. A., Shabon U., Trill J. J., Hay D.W. P., Ohlstein E. H., Bergsma D. J., Dougls S. A. Human Urotensin-II is a Potent Vasoconstrictor and Agonist for the Orphan Receptor GPR14. Nature 1999; 401: 282–286
   PubMed Web of Science ®Google Scholar
• Nothacker H. P., Wang Z., McNeill A. M., Saito Y., Merten S., O'Dowd B., Duckles S. P., Civelli O. Identification of the Natural Ligand of an Orphan G-Protein-Coupled Receptor Involved in the Regulation of Vasoconstriction. Nat. Cell Biol. 1999; 1: 383–385
   PubMed Web of Science ®Google Scholar
• Liu Q., Pong S. S., Zeng Z., Zhang Q., Howard A. D., Williams D. L., Jr., Davidoff M., Wang R., Austin C. P., McDonald T. P., Bai C., George S. R., Evans J. F., Caskey C. T. Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14. Biochem. Biophys. Res. Commun. 1999; 266: 174–178
   PubMed Web of Science ®Google Scholar
• Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., Kikuchi K., Shintani Y., Kurokawa T., Onda H., Nishimura O., Fujino M. Urotensin II is the Endogenous Ligand of a G-Protein-Coupled Orphan Receptor, SENR (GPR14). Biochem. Biophys. Res. Commun. 1999; 265: 123–129
   PubMed Web of Science ®Google Scholar
• Maguire J. J., Kuc R. E., Davenport A. P. Orphan-Receptor Ligand Human Urotensin II: Receptor Localization in Human Tissues and Comparison of Vasoconstrictor Responses with Endothelin-1. Br. J. Pharmacol. 2000; 131: 441–446
   PubMed Web of Science ®Google Scholar
• Eguchi S., Dempsey P. J., Frank G. D., Motley E. D., Inagami T. Activation of MAP Kinases by Angiotensin II in Vascular Smooth Muscle Cells: Metalloprotease-Dependent EGF Receptor Activation is Required for Activation of ERK and p38 MAP Kinase, but Not for JNK. J. Biol. Chem. 2000; 276: 7957–7962
   PubMedGoogle Scholar
• Yue T. L., Gu J. L., Wang C., Reith A. D., Lee J. C., Mirabile R. C., Kreutz R., Wang Y., Maleeff B., Parsons A. A., Ohlstein E. H. Extracellular Signal-Regulated Kinase Plays an Essential Role in Hypertrophic Agonists, Endothelin-1 and Phenylephrine-Induced Cardiomyocyte Hypertrophy. J. Biol. Chem. 2000; 275: 37895–37901
   PubMedGoogle Scholar
• Aharonovitz O., Aboulafia-Etzion S., Leor J., Battler A., Granot Y. Stimulation of 42/44 kDa Mitogen-Activated Protein Kinases by Arginine Vasopressin in Rat Cardiomyocytes. Biochim. Biophys. Acta 1998; 1401: 105–111
   PubMedGoogle Scholar
• Weber K. T., Sun Y., Guarda E. Structural Remodeling in Hypertensive Heart Disease and the Role of Hormones. Hypertension 1994; 23: 869–877
   PubMed Web of Science ®Google Scholar
• Morrell N. W., Upton P. D., Kotecha S., Huntley A., Yacoub M. H., Polak J. M., Wharton J. Angiotensin II Activates MAPK and Stimulates Growth of Human Pulmonary Artery Smooth Muscle via AT1 Receptors. Am. J. Physiol. 1999; 277: L440–L448
   Google Scholar
• Bogoyevitch M. A., Glennon P. E., Andersson M. B., Clerk A., Lazou A., Marshall C. J., Parker P. J., Sugden P. H. Endothelin-1 and Fibroblast Growth Factors Stimulate the Mitogen- Activated Protein Kinase Signaling Cascade in Cardiac Myocytes. The Potential Role of the Cascade in the Integration of Two Signaling Pathways Leading to Myocyte Hypertrophy. J. Biol. Chem. 1994; 269: 1110–1119
   PubMedGoogle Scholar
• Nayler O., Hartmann A. M., Stamm S. The ER Repeat Protein YT521-B Localizes to a Novel Subnuclear Compartment. J. Cell Biol. 2000; 150: 949–962
   PubMed Web of Science ®Google Scholar
• Davenport A. P., Maguire J. J. Urotensin II: Fish Neuropeptide Catches Orphan Receptor. Trends Pharmacol. Sci. 2000; 21: 80–82
   PubMedGoogle Scholar
• Gibson A., Conyers S., Bern H. A. The Influence of Urotensin II on Calcium Flux in Rat Aorta. J. Pharm. Pharmacol. 1988; 40: 893–895
   PubMedGoogle Scholar
• Opgaard O. S., Nothacker H., Ehlert F. J., Krause D. N. Human Urotensin II Mediates Vasoconstriction via an Increase in Inositol Phosphates. Eur. J. Pharmacol. 2000; 406: 265–271
   PubMedGoogle Scholar
• Douglas S. A., Aiyar N. V., Willette R. N. (Circulation 2000) Human Urotensin-II-Induced Vasoconstriction is Attenuated by Inhibition of Phospholipase C-Mediated [Ca2 + ]-Signaling and by PKC/Calmodulin Antagonism. Conference of the American Heart Association, New OrleansLouisiana, Nov, 2000. New OrleansLouisiana, 11–13, 540
   Google Scholar
• Zhang X. F., Iwamuro Y., Okamoto Y., Kawanabe Y., Masaki T., Miwa S. Endothelin-1-Induced Contraction of Rat Thoracic Aorta Depends on Calcium Entry Through Three Types of Calcium Channel. J. Cardiovasc. Pharmacol. 2000; 36: S105–S106
   Google Scholar
• Luttrell L. M., Hawes B. E., van Biesen T., Luttrell D. K., Lansing T. J., Lefkowitz R. J. Role of c-Src Tyrosine Kinase in G Protein-Coupled Receptor- and Gbetagamma Subunit-Mediated Activation of Mitogen-Activated Protein Kinases. J. Biol. Chem. 1996; 271: 19443–19450
   PubMed Web of Science ®Google Scholar
• Hawes B. E., van Biesen T., Koch W. J., Luttrell L. M., Lefkowitz R. J. Distinct Pathways of Gi‐ and Gq-Mediated Mitogen-Activated Protein Kinase Activation. J. Biol. Chem. 1995; 270: 17148–17153
   PubMedGoogle Scholar
• Hawes B. E., Luttrell L. M., van Biesen T., Lefkowitz R. J. Phosphatidylinositol 3-Kinase is an Early Intermediate in the G Beta Gamma-Mediated Mitogen-Activated Protein Kinase Signaling Pathway. J. Biol. Chem. 1996; 271: 12133–12136
   PubMedGoogle Scholar
• Gutkind J. S. Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors, http://www.stke.org/cgi/content/full/OC_sigtrans; 2000/40/re1
   Google Scholar
• Koch W. J., Hawes B. E., Inglese J., Luttrell L. M., Lefkowitz R. J. Cellular Expression of the Carboxyl Terminus of a G Protein-Coupled Receptor Kinase Attenuates G Beta Gamma-Mediated Signaling. J. Biol. Chem. 1994; 269: 6193–6197
   PubMedGoogle Scholar
• Hackel P. O., Zwick E., Prenzel N., Ullrich A. Epidermal Growth Factor Receptors: Critical Mediators of Multiple Receptor Pathways. Curr. Opin. Cell Biol. 1999; 11: 184–189
   PubMed Web of Science ®Google Scholar
• Tzanidis A., Hannan R. D., Thomas W. G., Onan D., See F., Krum H. Urotensin II Stimulates Collagen Synthesis by Cardiac Fibroblasts and Hypertrophic Signalling in Cardiomyocytes via (Galpha)q- and Ras-Dependent Pathways, Abstract at American College Cardiology Conference, Orlando, Florida, March 2000. J. Am. Coll. Cardiol. 2001; Suppl A: 164A
   Google Scholar
• Watanabe T., Pakala R., Katagiri T., Benedicte C. R. Synergistic Effect of Urotensin II with Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells. Circulation 2001; 104: 16–18
   PubMed Web of Science ®Google Scholar
• Sauzeau V., Le Mellionnec E., Bertoglio J., Scalbert E., Pacaud P., Loirand G. Human Urotensin II-Induced Contraction and Arterial Smooth Muscle Cell Proliferation are Mediated by RhoA and Rho-kinase. Circulation Res. 2001; 88: 1102–1104
   PubMed Web of Science ®Google Scholar